Correlation Between Viracta Therapeutics and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Viracta Therapeutics and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Actinium Pharmaceuticals.
Diversification Opportunities for Viracta Therapeutics and Actinium Pharmaceuticals
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viracta and Actinium is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Actinium Pharmaceuticals
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Actinium Pharmaceuticals. In addition to that, Viracta Therapeutics is 2.79 times more volatile than Actinium Pharmaceuticals. It trades about -0.28 of its total potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about 0.15 per unit of volatility. If you would invest 117.00 in Actinium Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of 64.00 from holding Actinium Pharmaceuticals or generate 54.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 42.62% |
Values | Daily Returns |
Viracta Therapeutics vs. Actinium Pharmaceuticals
Performance |
Timeline |
Viracta Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Actinium Pharmaceuticals |
Viracta Therapeutics and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viracta Therapeutics and Actinium Pharmaceuticals
The main advantage of trading using opposite Viracta Therapeutics and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Actinium Pharmaceuticals vs. Mink Therapeutics | Actinium Pharmaceuticals vs. Affimed NV | Actinium Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Actinium Pharmaceuticals vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |